Germany's Pharmacists' Union Overhauls Structure Under New Leadership

Germany's Federal Union of German Associations of Pharmacists (ABDA) is undergoing a major internal restructure. The organization has replaced its old divisional system with 14 newly consolidated departments, all reporting to the central executive board. The changes come as Franziska Erdle takes over as chief executive, with Claudia Korf moving into a vice executive role.

The ABDA previously operated through autonomous areas, each with its own director and separate divisions. Under the new system, the 14 departments will either report directly to Erdle or to Korf, who will oversee eight of them. This shift follows the retirement of former directors Lutz Tisch (Legal Affairs) and Professor Dr. Martin Schulz (Medicines), while the Pharmacy position, last held by Dr. Christiane Eckert-Lill, will not be refilled.

The restructure aims to make the ABDA more agile and effective. All newly appointed department heads have years of experience within the organization, which employs around 130 staff at its central office. The transition is expected to finish by midyear.

Over the past five years, the ABDA has expanded its political influence. Lobbying meetings with Bundestag members rose by 25%, from 150 to 190 annually, while participation in parliamentary hearings doubled. The focus has shifted from cost-control advocacy to proactive initiatives, including leading the 2024 Apothekenstärkungsgesetz and collaborating with the Health Ministry on AI regulations for pharmacies.

The changes mark a move toward a more streamlined and responsive organization. With Erdle at the helm and Korf in a vice executive role, the ABDA will now operate under a centralized structure. The new system is designed to enhance efficiency and maintain the union's growing role in health policy.